SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade.

Grippin AJ, Marconi C, Copling S, Li N, Braun C, Woody C, Young E, Gupta P, Wang M, Wu A, Jeong SD, Soni D, Weidert F, Xie C, Goldenberg E, Kim A, Zhao C, DeVries A, Castillo P, Lohray R, Rooney MK, Schrank BR, Wang Y, Ma Y, Chang E, Kouzy R, Dyson K, Jafarnia J, Nariman N, Gladish G, New J, Argueta A, Amaya D, Thomas N, Doty A, Chen J, Copling N, Alatrash G, Simon J, Davies AB, Dennis W, Liang R, Lewis J, Wei X, Rinsurongkawong W, Vaporciyan AA, Johns A, D3CODE Team, Lee J, Lee JH, Sun R, Sharma P, Tran H, Zhang J, Gibbons DL, Wargo J, Kim BYS, Heymach JV, Mendez-Gomez HR, Jiang W, Sayour EJ, Lin SH

Open source

DOI
10.1038/s41586-025-09655-y
Published
2025 Nov
Container
Nature
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41586-025-09655-y,
  title = {SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade.},
  author = {Grippin AJ and Marconi C and Copling S and Li N and Braun C and Woody C and Young E and Gupta P and Wang M and Wu A and Jeong SD and Soni D and Weidert F and Xie C and Goldenberg E and Kim A and Zhao C and DeVries A and Castillo P and Lohray R and Rooney MK and Schrank BR and Wang Y and Ma Y and Chang E and Kouzy R and Dyson K and Jafarnia J and Nariman N and Gladish G and New J and Argueta A and Amaya D and Thomas N and Doty A and Chen J and Copling N and Alatrash G and Simon J and Davies AB and Dennis W and Liang R and Lewis J and Wei X and Rinsurongkawong W and Vaporciyan AA and Johns A and D3CODE Team and Lee J and Lee JH and Sun R and Sharma P and Tran H and Zhang J and Gibbons DL and Wargo J and Kim BYS and Heymach JV and Mendez-Gomez HR and Jiang W and Sayour EJ and Lin SH},
  year = {2025},
  journal = {Nature},
  doi = {10.1038/s41586-025-09655-y},
  url = {https://doi.org/10.1038/s41586-025-09655-y}
}

RIS

TY  - JOUR
TI  - SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade.
AU  - Grippin AJ
AU  - Marconi C
AU  - Copling S
AU  - Li N
AU  - Braun C
AU  - Woody C
AU  - Young E
AU  - Gupta P
AU  - Wang M
AU  - Wu A
AU  - Jeong SD
AU  - Soni D
AU  - Weidert F
AU  - Xie C
AU  - Goldenberg E
AU  - Kim A
AU  - Zhao C
AU  - DeVries A
AU  - Castillo P
AU  - Lohray R
AU  - Rooney MK
AU  - Schrank BR
AU  - Wang Y
AU  - Ma Y
AU  - Chang E
AU  - Kouzy R
AU  - Dyson K
AU  - Jafarnia J
AU  - Nariman N
AU  - Gladish G
AU  - New J
AU  - Argueta A
AU  - Amaya D
AU  - Thomas N
AU  - Doty A
AU  - Chen J
AU  - Copling N
AU  - Alatrash G
AU  - Simon J
AU  - Davies AB
AU  - Dennis W
AU  - Liang R
AU  - Lewis J
AU  - Wei X
AU  - Rinsurongkawong W
AU  - Vaporciyan AA
AU  - Johns A
AU  - D3CODE Team
AU  - Lee J
AU  - Lee JH
AU  - Sun R
AU  - Sharma P
AU  - Tran H
AU  - Zhang J
AU  - Gibbons DL
AU  - Wargo J
AU  - Kim BYS
AU  - Heymach JV
AU  - Mendez-Gomez HR
AU  - Jiang W
AU  - Sayour EJ
AU  - Lin SH
PY  - 2025
JO  - Nature
DO  - 10.1038/s41586-025-09655-y
UR  - https://doi.org/10.1038/s41586-025-09655-y
ER  -

APA

AJ, G., C, M., S, C., N, L., C, B., C, W., E, Y., P, G., M, W., A, W., SD, J., D, S., F, W., C, X., E, G., A, K., C, Z., A, D., P, C., R, L., MK, R., BR, S., Y, W., Y, M., E, C., R, K., K, D., J, J., N, N., G, G., J, N., A, A., D, A., N, T., A, D., J, C., N, C., G, A., J, S., AB, D., W, D., R, L., J, L., X, W., W, R., AA, V., A, J., Team, D., J, L., JH, L., R, S., P, S., H, T., J, Z., DL, G., J, W., BYS, K., JV, H., HR, M., W, J., EJ, S., & SH, L. (2025). SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade.. Nature. https://doi.org/10.1038/s41586-025-09655-y

Source records